Clinical trial NCT04072419: Application of Enhanced Recovery After Surgery for Congenital Esophageal Atresia During Perioperative Period
Official title: Application of Enhanced Recovery After Surgery for Congenital Esophageal Atresia During Perioperative Period
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Esophageal Atresia
Enhanced Recovery After Surgery
Keywords: esophageal atresia
enhanced recovery after surgery
perioperative management
Lead sponsor: Guangzhou Women and Children's Medical Center
Sponsor class: OTHER
First posted: 2019-08-28
Enrollment: 40
Sex: ALL
Minimum age (years): 1
Maximum age (years): 1
Standard ages: CHILD
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: The study population includes congenital esophageal atresia with type C present to Guangzhou Women and Children's Medical Center

Brief summary: The purpose of this prospective cohort study is to evaluate the safety and effectiveness of enhanced recovery after surgery (ERAS) to perform routine thoracoscopic repair for elective esophageal atresia type C

Detailed description: The concept of enhanced recovery after surgery was introduced by Kelhet et al. in the 1990s for colorectal surgery, and it referred to a group of measures performed during a patient's treatment course to improve operative outcomes, reduce complications, and speed up patient recovery. It is now widely applied in many surgical fields, such as thoracic surgery The esophageal atresia is a group of birth defects including a break in continuity of the esophagus with or without persistent communication with the trachea (tracheoesophageal fistula), and occurs in approximately 1 in 3500-4500 births. Refinements in surgical technique and perioperative care have dramatically decreased mortality rates of infants with EA/TEF, such that mortality is generally related to associated anomalies. Accordingly, the current focus in optimizing patient outcomes has shifted toward decreasing morbidity, including minimizing postoperative complications, speeding up recovery. One of the milestones in recent years is the introduction and rapid development of video-assisted thoracoscopic surgery (VATS). This surgical method has beneficial effects on patient's post-operative recovery and functional status without compromising surgical resection. A range of operations can now be safely performed via VATS.

Although the survival rate of EA is more than 90 percent, there are still many postoperative complications, including anastomotic leakage, recurrence of esophagotracheal fistula, esophageal stenosis, gastroesophageal reflux and other problems, which seriously affect the prognosis. For decades, in order to reduce the complications, post-operative muscle paralysis, mechanical ventilation and urinary catheterization were performed for at least 2 days as convention perioperative management. However, complications after general anesthesia and endotracheal intubation are not negligible, and urinary catheterization is associated with urethral trauma, discomfort, infection. The main reason for placement of chest tube is for post-operative monitoring. However, a chest drain is a recognized cause of post-operative pain and can affect patient's post-operative morbility as well as effective chest physiotherapy.

The current project aims to explored the possibility of ERAS approach (i.e. weaning mechanical ventilation after surgery (less than 48h), no post-operative chest tube and urinary catheterization) for specific Type C EA (the distance of blind end is less than 2.5cm, weight\>2.4Kg, without related malformations (heart, kidney, for example), and without structural heart disease (excluding patent ductus arteriosus, patent foramen ovale, or atrial septal defect)).

Eligibility criteria: Inclusion Criteria:

1. congenital esophageal atresia with type C
2. the distance of blind end is less than 2.5cm
3. weight\>2.4Kg
4. without related malformations (heart, kidney),
5. without structural heart disease (excluding patent ductus arteriosus, patent foramen ovale, or atrial septal defect)

Exclusion Criteria:

1. Type A/B/D/E esophageal atresia
2. the distance of blind end is more than 2.5cm
3. weight is less than 2.4Kg
4. with Inherited chromosomal related diseases
5. with congenital heart disease (excluding patent ductus arteriosus, patent foramen ovale, or atrial septal defect)
6. preoperative severe pneumonia need mechanical ventilation

Primary outcomes:
measure: Number of participants with post-operative anastomotic leak
timeFrame: one month after surgery
measure: Number of participants with post-operative recurrent fistula
timeFrame: two years after surgery
measure: Number of participants with post-operative anastomotic strictures
timeFrame: two years after surgery
measure: Total number of participants with post-operative complications
timeFrame: two years after surgery
Secondary outcomes:
measure: length of stay
timeFrame: up to 24 weeks
measure: Length of nutritional support in hospital
timeFrame: up to 24 weeks
Other outcomes:
Locations:
city: Guangzhou
country: China
facility: Guangzhou Women and Children's Medical Cente
Study officials:
References: